Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer-Reference-Cited by-同舟云学术

Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer

Published:2018-11 Issue: Volume:125 Page:157-163
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Djureinovic Dijana,Dodig-Crnković Tea^ORCID,Hellström Cecilia,Holgersson Georg,Bergqvist Michael,Mattsson Johanna S.M.,Pontén Fredrik,Ståhle Elisabeth,Schwenk Jochen M.^ORCID,Micke Patrick

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference40 articles.

1. PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: new development and challenges;Meng;Cancer Lett.,2017

2. Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer;Anagnostou;Clin. Cancer Res.,2015

3. Emerging opportunities and challenges in Cancer immunotherapy;Whiteside;Clin. Cancer Res.,2016

4. Progress and challenges of predictive biomarkers of anti PD-1/PD-L1 immunotherapy: a systematic review;Teng;Cancer Lett.,2018

5. MHC class II restricted neoantigen: a promising target in tumor immunotherapy;Sun;Cancer Lett.,2017

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of seven tumor-associated autoantibodies in the diagnosis, staging and treatment guidance of lung cancer;BMC Pulmonary Medicine;2024-05-21

2. Autoantibodies:Powerful Biomakers in Cancer and Autoimmune Disease Precision Medicine;2023 2nd International Conference on Ambient Intelligence in Health Care (ICAIHC);2023-11-17

3. Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review);International Journal of Oncology;2023-05-05

4. Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients;OncoImmunology;2022-10-05

5. Comprehensive Analysis of the Carcinogenic Process, Tumor Microenvironment, and Drug Response in HPV-Positive Cancers;Frontiers in Oncology;2022-03-22